UGT2A3 and malignant colon neoplasm: Results showed that UGT2A3 was significantly downregulated in tumor tissues in both the TCGA COAD cohort (Figure 5A) and GSE83889 (Figure 5C), with excellent diagnostic effectiveness for colon cancer.